OTCMKTS:TMED Trimedyne (TMED) Stock Price, News & Analysis → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free TMED Stock Alerts $4.25 -0.01 (-0.23%) (As of 03/20/2020) Add Compare Share Share Today's Range$4.25▼$4.2550-Day Range$4.25▼$4.2552-Week Range$3.48▼$7.00Volume100 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Trimedyne alerts: Email Address Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! About Trimedyne Stock (OTCMKTS:TMED)Trimedyne, Inc. manufactures and sells lasers, and disposable and reusable fiber-optic laser devices for use in the medical field. It offers lasers, fibers, needles, and switch tips for use in orthopedics, urology, ear and nose surgery, throat surgery, gynecology, gastrointestinal surgery, general surgery, and other medical specialties. The company also provides 80 watt and 30 watt holmium lasers, and side firing laser needles to treat herniated or ruptured spinal discs. In addition, it engages in the provision of services, and rental of lasers and other medical equipment to hospitals and surgery centers on a fee-per-case basis. The company operates in Asia, Europe, Latin America, the Middle East, Australia, and internationally. It markets its products through commission sales representatives in the United States and independent distributors internationally. Trimedyne, Inc. was founded in 1980 and is based in Irvine, California.Read More TMED Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TMED Stock News HeadlinesApril 25, 2024 | americanbankingnews.comTrimedyne (OTCMKTS:TMED) Shares Pass Below Two Hundred Day Moving Average of $4.25See More Headlines Receive TMED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trimedyne and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/20/2018Today4/25/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Electromedical equipment Sub-IndustryN/A Current SymbolOTCMKTS:TMED CUSIPN/A CIK357001 Webwww.trimedyne.com Phone949-951-3800Fax949-855-8206EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Glenn D. Yeik (Age 51)Interim Chairman, CEO & Pres Mr. Brian T. Kenney (Age 62)VP of Global Sales & Marketing Key Competitors(UPGI)OTCMKTS:UPGI01 Communique LaboratoryOTCMKTS:OCQLF12 ReTechOTCMKTS:RETC1mage SoftwareOTCMKTS:ISOL24SevenOffice Group AB (publ)OTCMKTS:TFSVFView All Competitors TMED Stock Analysis - Frequently Asked Questions How have TMED shares performed in 2024? Trimedyne's stock was trading at $4.25 at the start of the year. Since then, TMED shares have increased by 0.0% and is now trading at $4.25. View the best growth stocks for 2024 here. How were Trimedyne's earnings last quarter? Trimedyne, Inc. (OTCMKTS:TMED) released its quarterly earnings results on Tuesday, February, 20th. The technology company reported $0.70 EPS for the quarter. The technology company earned $1.53 million during the quarter. What other stocks do shareholders of Trimedyne own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trimedyne investors own include Aflac (AFL), Diana Shipping (DSX), Cohen & Steers Closed-End Opportunity Fund (FOF), Incyte (INCY), National Fuel Gas (NFG), PDC Energy (PDCE), The Rank Group (RNK), Safehold (SAFE), Snap (SNAP) and Aramark (ARMK). How do I buy shares of Trimedyne? Shares of TMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TMED) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe AI stock to buy right nowStockEarningsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trimedyne, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.